← Back to headlines

PFS as a Surrogate for OS in First-Line Immunotherapy: Results from 18 Trials Meta-Analysis in GEA and ESCC

This story is reported by Oncodaily. Read what other outlets are saying below, then open the original report for full details.

PFS as a Surrogate for OS in First-Line Immunotherapy: Results from 18 Trials Meta-Analysis in GEA and ESCC · NabkaNews